Takeaway

• The MIRAGE randomised clinical trial (RCT) of magnetic resonance imaging (MRI)-guided versus computed tomography (CT)-guided stereotactic body radiotherapy (SBRT) for localised prostate cancer reduced margins by 2 mm and reduced the incidence of acute (90 days or less) genitourinary (GU) toxicity (grade 2 or greater), the primary outcome, by...